Harvard Bioscience, Inc. (HBIO)
8.03
-0.12
(-1.47%)
USD |
NASDAQ |
Sep 11, 16:00
8.06
+0.03
(+0.37%)
After-Hours: 20:00
Harvard Bioscience Market Cap : 36.56M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 36.56M |
| September 10, 2026 | 37.10M |
| September 09, 2026 | 36.19M |
| September 08, 2026 | 36.19M |
| September 04, 2026 | 36.51M |
| September 03, 2026 | 36.42M |
| September 02, 2026 | 37.33M |
| September 01, 2026 | 36.60M |
| August 31, 2026 | 36.92M |
| August 28, 2026 | 36.10M |
| August 27, 2026 | 35.96M |
| August 26, 2026 | 34.83M |
| August 25, 2026 | 34.51M |
| August 24, 2026 | 34.37M |
| August 21, 2026 | 34.05M |
| August 20, 2026 | 34.37M |
| August 19, 2026 | 32.23M |
| August 18, 2026 | 31.73M |
| August 17, 2026 | 29.59M |
| August 14, 2026 | 30.30M |
| August 13, 2026 | 30.36M |
| August 12, 2026 | 28.09M |
| August 11, 2026 | 27.91M |
| August 10, 2026 | 29.09M |
| August 07, 2026 | 29.45M |
| Date | Value |
|---|---|
| August 06, 2026 | 27.92M |
| August 05, 2026 | 28.73M |
| August 04, 2026 | 28.46M |
| August 03, 2026 | 28.46M |
| July 31, 2026 | 27.51M |
| July 30, 2026 | 27.47M |
| July 29, 2026 | 27.60M |
| July 28, 2026 | 26.70M |
| July 27, 2026 | 27.02M |
| July 24, 2026 | 27.06M |
| July 23, 2026 | 27.92M |
| July 22, 2026 | 27.65M |
| July 21, 2026 | 27.24M |
| July 20, 2026 | 27.56M |
| July 17, 2026 | 28.10M |
| July 16, 2026 | 26.84M |
| July 15, 2026 | 27.20M |
| July 14, 2026 | 26.75M |
| July 13, 2026 | 27.60M |
| July 10, 2026 | 27.69M |
| July 09, 2026 | 28.10M |
| July 08, 2026 | 28.32M |
| July 07, 2026 | 29.90M |
| July 06, 2026 | 28.64M |
| July 02, 2026 | 27.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agilent Technologies, Inc. | 41.43B |
| Bio-Rad Laboratories, Inc. | 9.875B |
| Bruker Corp. | 8.140B |
| Danaher Corp. | 140.68B |
| Illumina, Inc. | 31.17B |
Market Cap Related Metrics
| PS Ratio | 0.4096 |
| PEG Ratio | -0.1088 |
| Price to Book Value | 4.928 |
| Price | 8.03 |
| Earnings Yield | -28.93% |
| PEGY Ratio | -0.1088 |
| Operating PE Ratio | 62.76 |